No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening

Objective Congenital adrenal hyperplasia (CAH) is not currently included in the UK newborn screening programme. We investigated the hypothesis that, owing to non-specificity of symptoms, a proportion of males affected by salt-wasting (SW) CAH have died in infancy without being diagnosed. Design Stor...

Ausführliche Beschreibung